Healthcare


 ResMed (ASX:RMD) to acquire MEDIFOX DAN in US$1.0B deal

ResMed (ASX:RMD) to acquire MEDIFOX DAN in US$1.0B deal

June 15, 2022 03:25 PM AEST| By Sonal Goyal

Medical device manufacturing company, ResMed Inc (ASX:RMD), has shared on Wednesday, that it will acquire MEDIFOX DAN for US$1.0 billion, under a definitive agreement. MEDIFOX DAN is a leader in out-of-hospital software solutions providers. ResMed.....

 Pro Medicus (ASX:PME) inks two contract renewals worth AU$47M

Pro Medicus (ASX:PME) inks two contract renewals worth AU$47M

June 14, 2022 01:24 PM AEST| By Sonal Goyal

Highlights Pro Medicus has signed a renewal contract with Sutter Health for another seven years. A renewal contract is also inked with Wellspan Health for further five years. The share price of Pro Medicus has gained by over 650% in last 5 yea.....

 Healthcare value stocks from ASX All Ordinaries: HLS, MVF, SHL, ANN

Healthcare value stocks from ASX All Ordinaries: HLS, MVF, SHL, ANN

June 13, 2022 12:07 AM AEST| By Aditi Sarkar

Highlights Value stocks trade at a lower price corresponding to their fundamentals A high dividend yield and low P/B P/E ratios are common features of value stocks Healius reported a 100% increment in underlying unaudited EBITDA YTD to May 202.....

 Pro Medicus signs US$28M contract with Allina Health; how are shares faring?

Pro Medicus signs US$28M contract with Allina Health; how are shares faring?

June 02, 2022 10:54 AM AEST| By Ashish

Highlights Pro Medicus signed a 7-year contract with a Minneapolis-based firm Allina Health. The deal with Alline Health is worth AU$28 million. The deal is expected to provide a unified diagnostic imaging platform across the network...

 Recent updates from ASX healthcare stocks DXB and GLH

Recent updates from ASX healthcare stocks DXB and GLH

June 01, 2022 04:01 PM AEST| By Aditi Sarkar

Highlights Dimerix recruits the first subject for its DMX-200 phase 3 trial in patients with FSGS kidney disease. FSGS has a huge market opportunity as in the US alone, end stage renal failure amounted to an estimated cost of US$55 billion per .....

 Mesoblast (ASX:MSB) posts US$23.1M third-quarter loss; how are shares faring?

Mesoblast (ASX:MSB) posts US$23.1M third-quarter loss; how are shares faring?

June 01, 2022 11:14 AM AEST| By Ashish

Highlights Mesoblast’s loss after tax for the third quarter FY2022 was US$21.3 million. Total revenue rose 5% from the comparative quarter last year to US$2 million. Despite the loss, Mesoblast’s share price was trading a...

 CSL, RHC, SHL: 3 ASX health care stocks on investors’ watchlist  

CSL, RHC, SHL: 3 ASX health care stocks on investors’ watchlist  

May 31, 2022 02:20 PM AEST| By Aditi Sarkar

Highlights CSL has the largest market capitalisation (AU$131.32 billion) in the ASX health care space as of 31 May 2022 In 2020/21, CSL invested US$1,001 million in R&D activities Sonic reported revenue growth of 7% and net profit growth o.....

 A look at 2 ASX-listed dental care stocks: SDI, PSQ

A look at 2 ASX-listed dental care stocks: SDI, PSQ

May 31, 2022 11:54 AM AEST| By Aditi Sarkar

Highlights Private dental clinics cater to more than 85% of dental care in Australia. Dental care stock SDI, which registered record 1H sales, expects new product releases and continued increases in market share to underpin growth momentum. CO.....

 RAC, CTE, ADO: ASX health stocks with massive returns in past 3 years

RAC, CTE, ADO: ASX health stocks with massive returns in past 3 years

May 28, 2022 12:45 AM AEST| By Aditi Sarkar

Multibaggers are lucrative stocks that provide returns several times higher than their initial investment value. To be more specific, if a stock price rises by double, it's called a double bagger, while if the price grows multiple times, it's calle.....

 From REG to ICR: Latest updates from ASX-listed aged care stocks

From REG to ICR: Latest updates from ASX-listed aged care stocks

May 26, 2022 07:37 PM AEST| By Aditi Sarkar

Highlights The Australian government provides funding to a range of aged care homes Regis Healthcare provides care for over 7,200 people throughout Australia Swift Networks has secured a new agreement worth AU$1.5 million with Hubify Limited .....

 Volpara Health (ASX:VHT) exceeds revenue guidance in FY22

Volpara Health (ASX:VHT) exceeds revenue guidance in FY22

May 26, 2022 12:13 PM AEST| By Sonal Goyal

Highlights Volpara marked 32% increase in revenue from customer contracts to NZ$26.1 million. Volpara delivered gross profit margin of over 91% in FY22. Volpara recorded 45% surge in the cash receipts. Health care technology provider, Vol.....

 ALT and CDX: Why these ASX healthcare stocks were in news today

ALT and CDX: Why these ASX healthcare stocks were in news today

May 18, 2022 05:55 PM AEST| By Aditi Sarkar

Highlights The S&P/ASX 200 Health Care (AXHJ) is up today with a gain of 0.235% Shares of ALT ended Wednesday with an upsurge of 50% following the approval of European and Indian patents CardieX's CONNEQT Companion app gets an MDDS classif...

 WFL, OSL, AVE: Three ASX healthcare stocks with over 20% QTD returns

WFL, OSL, AVE: Three ASX healthcare stocks with over 20% QTD returns

May 17, 2022 10:52 AM AEST| By Aditi Sarkar

Highlights The Australian stock market closed on a higher note on Monday The benchmark of the ASX healthcare sector, S&P/ASX 200 Health Care, is up by 2.30% on a QTD basis WFL reported quarter-on-quarter cash receipts growth of 312% T.....

 CSL’s (ASX: CSL) Vifor Pharma acquisition se to get delayed, shares fall

CSL’s (ASX: CSL) Vifor Pharma acquisition se to get delayed, shares fall

May 12, 2022 03:27 PM AEST| By Sukriti Nair

Highlights CSL Limited share price drops about 1.69% by afternoon today (12 May, 1:PM AEST). CSL has warned of a delay in the Vifor pharma acquisition. CSL shares also track the broader market and healthcare sector downtrend. Shares of th.....

 Beamtree (ASX:BMT) signs US$7M contract with Ampath; shares surge 

Beamtree (ASX:BMT) signs US$7M contract with Ampath; shares surge 

May 10, 2022 01:23 PM AEST| By Ritwika

Highlights Beamtree has signed a five-year deal with Ampath for the implementation of its RippleDown software.  The total value of the contract is AU$9.7 million.  Backed by the announcement, the share price of Beamtree has gained mo.....

 PME, MDR, CSL: A look at three ASX healthcare growth stocks

PME, MDR, CSL: A look at three ASX healthcare growth stocks

May 08, 2022 12:25 AM AEST| By Aditi Sarkar

Highlights Growth stocks are shares of the company estimated to increase sales and earnings faster than the market These stocks are likely to provide good price appreciation in the future Growth stocks also serve as a good hedge against inflat...

 XPON subsidiary Wondaris expands reach by teaming up with Google CMU

XPON subsidiary Wondaris expands reach by teaming up with Google CMU

May 06, 2022 05:43 PM AEST| By Aditi Sarkar

Highlights XPN’s Wondaris platform has teamed up with Google’s CMU program The partnership will allow clients to upload high-value audiences safely through easy and clickable workflow Customers will now be able to deliver marketing.....

 3D Printing: A great approach in healthcare innovations

3D Printing: A great approach in healthcare innovations

May 05, 2022 07:30 PM AEST| By Aditi Sarkar

Highlights 3D printing technology is used in developing new surgical cuttings, patient-specific replicas of bones, organs and blood vessels The innovative technology has created long-lasting and better-fitting implants 3D printers that can rep...

 Clinuvel (ASX:CUV) shares upbeat results from afamelanotide drug trial

Clinuvel (ASX:CUV) shares upbeat results from afamelanotide drug trial

May 04, 2022 01:05 PM AEST| By Aditi Sarkar

Highlights: CUV has received encouraging outcomes from the first clinical study assessing afamelanotide as a treatment for a life-threatening brain injury. In the clinical study, five out of six patients receiving afamelanotide recovered well i.....

 IPD, MX1 & MDR: Three ASX health tech stocks with strong revenue in 3Q

IPD, MX1 & MDR: Three ASX health tech stocks with strong revenue in 3Q

May 04, 2022 11:27 AM AEST| By Aditi Sarkar

Highlights ImpediMed saw record results for total revenue and SOZO SaaS revenue in Q3. Micro-X achieved good growth in Mobile DR unit sales with expanded network, distributors and inventory on hand. MedAdvisor reported a 96.1% YoY surge in ope.....

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.